Clinical trial
Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of…
NCT00427908 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00427908 |
|---|---|
| Title | Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612 |
| Official title | Evaluate Non-Inferiority and Persistence of the Immune Response of GSK Biologicals' Meningococcal Vaccine 134612 Versus Meningitec™ or Mencevax™ ACWY in Healthy Subjects (1-10 Years of Age) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infections, Meningococcal |
| Intervention type | Biological |
| Interventions | GSK Biolgicals' meningococcal vaccine 134612 (Nimenrix), Mencevax™ ACWY, Meningitec™ |
| Enrollment | 613 |
| Start date | Feb 7, 2007 |
| Primary completion | Dec 3, 2007 |
| Completion | Dec 3, 2007 |
| First posted | Jan 29, 2007 |
| Last update posted | Jun 4, 2018 |
| Countries | Finland |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: